RK

Rupam Kumari

Active Director Managing Director DIN 08409231
DIN 08409231 First appointment Apr 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Rupam Kumari

Data last updated:

Rupam Kumari is a Managing Director at Ajuras Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Ajuras Pharmaceuticals Private Limited reported revenue of ₹2.99 Cr (FY 2025).

DIN 08409231
Primary Designation Managing Director
Industry Trading
First Appointment 01 Apr 2019
Oldest Company Age 7 yrs
Largest company Ajuras Pharmaceuticals Private Limited · ₹2.99 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director01 Apr 20192018₹2.99 Cr (FY 2025)Active

Board colleagues of Rupam Kumari

Directorship timeline

Open interactive timeline →
Ajuras Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rupam Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupam Kumari

Rupam Kumari currently holds 1 directorship: Ajuras Pharmaceuticals Private Limited (Managing Director, since 01 Apr 2019, revenue ₹2.99 Cr (FY 2025)).

Rupam Kumari was first appointed on 01 Apr 2019 as Managing Director at Ajuras Pharmaceuticals Private Limited.

The current boards of Rupam Kumari's companies include Jitendra Kumar (Ajuras Pharmaceuticals Private Limited), Manish Kumar (Ajuras Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available